New to the program this year, the Regenerative Medicine Forum will delve into the many different ways stem cell science and regenerative medicine are having an impact within the biotechnology and pharmaceutical industries today. The paradigm shifting potential of this field has been projected for more than a decade but within the past two years its impact has begun to be noticed in many parts of the biomedical world. One securities analyst has said, “I believe that cell technologies have the potential to be the greatest breakthrough in all of healthcare.”
These sessions will detail the reasons big pharma R&D managers, investors at various levels, and the reimbursement community have all started to watch the developments in this rapidly emerging field.
See the complete session line-up below.
Session ID: 2625
9:00 AM–10:00 AM Jun 25, Wednesday
10:15 AM–11:30 AM Jun 25, Wednesday
1:45 PM–2:45 PM Jun 25, Wednesday
3:00 PM–4:00 PM Jun 25, Wednesday
4:15 PM–5:15 PM Jun 25, Wednesday
5:15 PM–6:15 PM Jun 25, Wednesday
West Terrace (Right)
Professer, UCSF and Senior Investigator, Gladstone UCSF and Gladstone Institutes
Chief Executive Officer, Celgene Cellular Therapeutics EVP, Chief Operations Officer, Celgene Corporation